BMS_CA240-0005

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination with Other Agents in Participants with Advanced and/or Metastatic Solid Tumors with Homozygous MTAP Deletion (MountainTap-5)
Principal Investigator
Associate Professor of Medicine
Protocol Number
IRB: PRO00120376
NCT: NCT07492680
Phase
Phase II
ClinicalTrials.gov
Status
OPEN TO ACCRUAL
Participate